Celanese (CE) PT Raised to $138 at Goldman Sachs Following 1Q

Barclays Reinstates Celanese (CE) at Overweight

Barclays reinstates coverage on Celanese (NYSE: CE) with a Overweight rating and a price target of $140.00.

Analyst Duffy Fischer says headwinds are turning into tailwinds and believes the current valuation is attractive while noting that the story is compelling despite the... More

Celanese Corp. (CE) Raises Quarterly Dividend 17.4% to $0.54; 1.9% Yield

Celanese Corp. (NYSE: CE) declared a quarterly dividend of $0.54 per share, or $2.16 annualized. This is a 17.4% increase from the prior dividend of $0.46.

The dividend will be payable on May 10, 2018, to stockholders of record on April 30, 2018, with an ex-dividend date of April 27, 2018.

The... More

Celanese (CE) PT Raised to $141 at KeyBanc

KeyBanc raised its price target on Celanese (NYSE: CE) to $141.00 (from $131.00) while maintaining a Overweight rating.

Celanese (CE) PT Raised to $112 at Morgan Stanley

Morgan Stanley raised its price target on Celanese (NYSE: CE) to $112.00 (from $88.00) while maintaining a Equalweight rating.

Celanese (CE) PT Raised to $128 at RBC Capital; 'Exceptionally Strong Quarter'

RBC Capital raised its price target on Celanese (NYSE: CE) to $128.00 (from $124.00) while maintaining a Outperform rating.

Analyst Arun Viswanathan notes the company delivered an "exceptionally strong quarter" on improvement in the upstream Acetyls Chain.

Celanese (CE) PT Raised to $130 at Citi

Citi raised its price target on Celanese (NYSE: CE) to $130.00 (from $128.00) while maintaining a Buy rating.

Celanese (CE) PT Raised to $111 at Nomura/Instinet

Nomura/Instinet raised its price target on Celanese (NYSE: CE) to $111.00 (from $105.00) while maintaining a Neutral rating.

Celanese (CE) PT Raised to $137 at BMO Capital

Analyst B. Lodaya says "The company has the potential to shock the Street based on tightening markets."

BMO Capital raised its price target on Celanese (NYSE: CE) to $137.00 (from $131.00) while maintaining a Outperform rating.

Pre-Open Movers 04/17: (RNDA) (ROKU) (NFLX) Higher; (BLCM) (LADR) (SEAC) Lower (more...)

Today's Pre-Open Movers

Arcadia Biosciences (Nasdaq: RKDA) 12.5% HIGHER; announced plans to add its new reduced gluten (RG) wheat lines to its GoodWheat portfolio of branded ingredients. The company expects to have its first RG bread wheat flour available for commercial testing by the end of the year.

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) 8.6% LOWER; commenced an underwritten public offering of 7,000,000 shares of its common stock. All shares of common stock to... More

After-Hours Stock Movers 04/16: (NFLX) (ROKU) (CE) Higher; (SEAC) (BLCM) Lower (more...)

Today's After-Hours Movers

SeaChange Int'l (NASDAQ: SEAC) 8% LOWER; reported Q4 EPS of $0.10, $0.03 better than the analyst estimate of $0.07. Revenue for the quarter came in at $22.95 million versus the consensus estimate of $22.9 million.

Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) 7.5% LOWER; commenced an underwritten public offering of 7,000,000 shares of its common stock. All shares of common stock to be sold in the offering will be offered by Bellicum. The offering... More

Celanese Corp. (CE) Tops Q1 EPS by 48c

Celanese Corp. (NYSE: CE) reported Q1 EPS of $2.79, $0.48 better than the analyst estimate of $2.31. Revenue for the quarter came in at $1.85 billion versus the consensus estimate of $1.66 billion.

Outlook

"The first quarter of 2018 represents a combination of stronger industry fundamentals and the strength of our commercial models. In Engineered Materials,... More